#United States #Costa Mesa #health community #STARs #Stuttering Treatment

STARS Releases First Interdisciplinary Consensus Guidelines on Stuttering

In a significant advancement in the understanding and treatment of stuttering, the Stuttering Treatment and Research Society (STARS) has published the first interdisciplinary consensus guidelines pertaining to stuttering disorders. This announcement, made on August 19, 2026, in Costa Mesa, California, represents a collective effort by an international panel of 35 experts, including psychiatrists, neurologists, speech-language pathologists, and those who stutter themselves, to forge a more comprehensive approach to the treatment and management of this complex condition.

Historically, stuttering has been dismissed as a mere developmental hiccup or behavioral issue. Yet, the panel asserts that stuttering is a heterogeneous, brain-based disorder that must be recognized as such by the medical field. The guidelines consist of seven consensus statements that emphasize the necessity for a nuanced understanding of the condition.

Among these statements is the urgent call for a comprehensive, individualized approach to assessment and care. The panel underscores that health professionals play a pivotal role in diagnosing stuttering. They advocate for interdisciplinary collaboration that integrates family medicine, pediatrics, psychiatry, neurology, and speech-language pathology, arguing that this should become the standard protocol for treatment.

The guidelines also highlight that stuttering impacts more than just speech fluency; it affects an individual’s confidence, social interactions, and overall emotional health and functioning. Therefore, assessments should encompass these broader aspects rather than focusing solely on fluency metrics. Moreover, the need for expanded training for healthcare providers to better serve individuals who stutter is emphasized to alleviate gaps in current medical education.

One of the alarmingly significant findings of the guidelines is the caution against certain medications that may exacerbate stuttering symptoms. Psychiatrists and other prescribers are advised to reconsider the use of dopamine-enhancing medications, as some patients have reported worsened symptoms. Instead, the recommendations lean towards considering dopamine antagonists or partial agonists, like aripiprazole, which have shown greater efficacy in helping manage stuttering.

Despite emerging research elucidating the neurological underpinnings of stuttering, nearly 90 percent of respondents to the panel's inquiry regarded the existing treatment landscape as inadequate. Primary barriers identified include a shortage of trained professionals, lack of consistent diagnostic measures, and limited integration between medical and speech therapy practices. A prominent 85.7 percent of panel members indicated that individuals who stutter and their families often lack access to high-quality information about the disorder.

In response to these obstacles, the guidelines provide actionable recommendations for the clinical implementation of care strategies. Key considerations involve screening patients for comorbid conditions, individualized treatment plans, maintaining a close partnership with speech-language therapists, and training medical staff to support patients effectively.

Beyond disseminating these guidelines, STARS is committed to creating further resources for educators, employers, and the medical community, especially focusing on long-term support for individuals who stutter. The call for standardized diagnostic frameworks, validated outcome measures, and accessible treatment pathways is seen as essential for the future trajectory of stuttering care.

In conclusion, the STARS guidelines pave the way for a coordinated, interdisciplinary approach to stuttering treatment. This holistic view draws parallels to the historical challenges faced in managing other neuropsychiatric conditions, emphasizing the lessons that can be learned in advancing care for those who struggle with stuttering. The society's continued dedication to improving healthcare access for the approximately 80 million individuals worldwide who stutter underpins their mission to foster a more supportive environment in the medical community.

For more information about the efforts of STARS and to access the guidelines, visit stutteringresearch.org.